Search Within

Department of Medicine

Formats
  1. Journal Article (19579)
  2. Meeting Abstract (16038)
  3. Review (1149)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (235)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22314)
  2. Hematologic Malignancies, Division of (13268)
  3. Center for Hematologic Malignancies (11053)
  4. GSK Faculty (10642)
  5. Survivorship Research (9326)
  6. Division of Subspecialty Medicine (7533)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1068)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1052)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3721)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6457)
  2. Elsevier Inc. (4215)
  3. American Society of Hematology (4000)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2110)

More Publishers

Results (39603)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic germline variants among women with uterine cancer by ancestry: A commercial laboratory collaborative research registry study
    Journal Article

    Johnson, C. R.; Aryasomayajula, C.; Francoeur, A. A.; Stewart, C.; Sia, T. Y.; Darcy, K. M.; Tian, C.; Kapp, D. S.; Liu, Y. L.; Chan, J. K.
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Health-related quality-of-life profile and clinical outcomes in first-line advanced renal cell carcinoma: A modeling analysis based on the CheckMate 9ER study
    Journal Article

    Cella, D.; Derosa, M.; Floden, L.; Giles, R. H.; Lothgren, M.; Ogareva, A.; Powles, T.; Purnajo, I.; Choueiri, T. K.; Bergerot, C.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer
    Journal Article

    Gouda, M. A.; Voss, M. H.; Tawbi, H.; Gordon, M.; Tykodi, S. S.; Lam, E. T.; Vaishampayan, U.; Tannir, N. M.; Chaves, J.; Nikolinakos, P.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab, in patients with advanced malignancies
    Journal Article

    Janku, F.; Tan, D. S. P.; Martin-Liberal, J.; Takahashi, S.; Geva, R.; Gucalp, A.; Razak, A.; Kan, R.; Reiners, R.; Mataraza, J.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer
    Journal Article

    Hong, D. S.; Xu, R. H.; Shen, L.; Dierselhuis, M. P.; Orbach, D.; McDermott, R.; Italiano, A.; Tahara, M.; Bernard-Gauthier, V.; Neu, N.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
    Journal Article

    Yin, Y.; Xu, H.; He, L.; Brown, J. R.; Mato, A. R.; Aittokallio, T.; Skånland, S. S.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Clinical implications of the cancer genome atlas molecular classification system in esophagogastric cancer
    Journal Article

    Walch, H. S.; Borpatragohain, R.; Jee, J.; Chatila, W.; Fong, C.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; Wu, A. J.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Safety and tolerability of lete-cel in NSCLC—Reply
    Correspondence

    Altan, M.; Lopes, G.; Hiltermann, T. J. N.; Govindan, R.; Villaruz, L. C.; Calvo, E.; Edelman, M. J.; Furqan, M.; Neal, J.; Felip, E.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of the HIF-2 alpha inhibitor DFF332 in patients with advanced clear-cell renal cell carcinoma
    Journal Article

    Pal, S. K.; Bernard-Tessier, A.; Grell, P.; Gao, X.; Kotecha, R. R.; Picus, J.; de Braud, F.; Takahashi, S.; Wong, A.; Suárez, C.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Treatment deintensification in locally advanced rectal cancer: When less is more [Interview]
    Miscellaneous

    Cercek, A.
    Clinical Advances in Hematology & Oncology (2025)

    Fulltext@MSK | Save